Clinical Trial Update: Phase I/II Combination With Irinotecan- Erbitux [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the completed Phase I/II study of combining irinotecan with cetuximab (Erbitux) in metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• ERBITUX (cetuximab)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Metastatic Colorectal Cancer (MCRC) | Phase 1, Phase 2 | Status: COMPLETED